Diselenide‐Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Chen Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237, China. Hauptthemen laut MEDLINE: Ferroptosis, Glutathione. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Key Laboratory of Advanced Polymeric Materials of Shanghai, Shanghai Jiao Tong University star of Jiao Tong University program medical and industrial cross-research fund.
Abstract (Originalsprache)
Glutathione (GSH) depletion‐induced ferroptosis has emerged as a promising treatment for malignant cancer. It works by inactivating glutathione peroxidase 4 (GPX4) and facilitating lipid peroxidation. However, effectively delivering inducers and depleting intracellular GSH remains challenging due to the short half‐lives and high hydrophobicity of small‐molecule ferroptosis inducers. These inducers often require additional carriers. Herein, diselenide‐containing polymers can consume GSH to induce ferroptosis for pancreatic cancer therapy. The diselenide bonds are controllably built into the backbone of the polycarbonate with a targeting peptide CRGD (Cys‐Arg‐Gly‐Asp), which allows for self‐assembly into stable nanoparticles (denoted CRNSe) for self‐delivery. Significantly, at a concentration of 12 µg mL −1 , CRNSe binds to the active site cysteine of GSH resulting in a thorough depletion of GSH. In contrast, the disulfide‐containing analog only causes a slight decrease in GSH level. Moreover, the depletion of GSH inactivates GPX4, ultimately inducing ferroptosis due to the accumulation of lipid peroxide in BxPC‐3 cells. Both in vitro and in vivo studies have demonstrated that CRNSe exhibits potent tumor suppressive ability with few side effects on normal tissue. This study validates the anti‐tumor mechanism of diselenide‐containing polymers in addition to apoptosis and also provides a new strategy for inherently inducing ferroptosis in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237, China.
- Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai, 200030, China.
ORCID-Profile: Meidong Lang
Förderung
- Key Laboratory of Advanced Polymeric Materials of Shanghai
- Shanghai Jiao Tong University star of Jiao Tong University program medical and industrial cross-research fund
Zitieren
APA
Zhou, C., Zhao, Y., Yang, M., Yin, W., Li, Y., Xiao, Y., Liu, Y., & Lang, M. (2024). Diselenide‐Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303896
Vancouver
Zhou C, Zhao Y, Yang M, Yin W, Li Y, Xiao Y, et al. Diselenide‐Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303896
BibTeX
@article{Zhou2024,
author = {Zhou, Chen and Zhao, Yuhao and Yang, Mao and Yin, Wang and Li, Yongsheng and Xiao, Yan and Liu, Yingbin and Lang, Meidong},
title = {Diselenide‐Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303896}
}
EUVIMED